Adial Pharmaceuticals Inc. (ADIL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Adial Pharmaceuticals Inc...

    NASDAQ: ADIL · Real-Time Price · USD
    0.47
    -0.14 (-22.46%)
    At close: Jul 30, 2025, 3:59 PM

    Adial Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.75M 2.83M 4M 6.06M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 981.83K 1.53M -601.01K -613.91K
    Other Long-Term Assets
    		 n/a n/a 455K 455K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 308.24K 371.6K 349.44K 389.5K
    Total Current Assets
    		 4.06M 3.2M 4.78M 6.46M
    Property-Plant & Equipment
    		 n/a n/a 244.42K 304.36K
    Goodwill & Intangibles
    		 3.35K 3.91K 708.45K 709.01K
    Total Long-Term Assets
    		 985.18K 1.54M 952.87K 1.01M
    Total Assets
    		 5.04M 4.74M 5.73M 7.47M
    Account Payables
    		 250.13K 127.39K 276.41K 286.19K
    Deferred Revenue
    		 n/a n/a n/a 2.38M
    Short-Term Debt
    		 n/a n/a 56.83K n/a
    Other Current Liabilities
    		 405.25K 104.32K 1.02M 1.87M
    Total Current Liabilities
    		 975.86K 653.08K 1.79M 2.72M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 0.00 492K 1.01M
    Total Long-Term Liabilities
    		 n/a 437.00 665.44K 1.24M
    Total Liabilities
    		 975.86K 653.08K 2.46M 3.97M
    Total Debt
    		 n/a n/a 207.38K 256.96K
    Book Value
    		 n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a
    Common Stock
    		 6.47K 1.66K 26.69K 20.95K
    Retained Earnings
    		 -82M -68.8M -63.67M -50.94M
    Comprehensive Income
    		 n/a n/a 0.00 -0.00
    Shareholders Equity
    		 4.07M 4.08M 3.28M 3.51M
    Total Investments
    		 981.83K 1.53M -601.01K -613.91K

    Add to Watchlist